Waleed Gado and T Mahdy
Mansoura University, Egypt
Al Qassimi Hospital, UAE
Scientific Tracks Abstracts: J Clin Gastroenterol Hepatol
Background: A lot of reports have shown that patients with body mass index (BMI)>35kg/m2 who underwent metabolic surgery experienced resolution of type 2 diabetes (T2DM). One of those bariatric surgery proved to be safe, effective, reliable and reversible is Mini-gastric bypass (MGB). Little studies addressed the efficacy of MGB on the resolution of T2DM in patients with BMI< 35 kg/m2. Objectives: We aimed to evaluate the efficacy of MGB on resolution of T2DM in patients with BMI< 35 kg/m2. Methods: From March 2011 to May 2015; 135 patients with T2DM and BMI<35 kg/m2 underwent MGB were enrolled in this study. The changes in fasting blood sugar (FBS), glycosylated haemoglobin (HbA1c), alanine transaminase (ALT), C-peptide, total body weight and the use of oral hypoglycemic agents and insulin at the end of one year were studied. Results: 108 patients (80 %) showed resolution, 25 patients (18.5 %) showed remission and only two patients (1.5 %) failed to respond after surgery as shown in fig1. There was statistically significant changes in BMI, FBS, and HbA1c (fig 2) one year post operatively with p-value<0.05. The duration of T2DM, preoperative treatment, ALT, and C-peptide seem to be of paramount importance as prognostic factors for resolution of T2DM after surgery. Conclusion: Our study showed that MGB is associated with a high rate of resolution of T2DM at 12 months after surgery in diabetic patients
Waleed Gado has completed his master’s degree in Surgery in 2008, PhD in 2014 from Mansoura University, Egypt. He is currently an Assistant Professor of Endocrine and Bariatric/ Metabolic Surgery. He is also a Consultant Surgeon in Egypt and Arab Gulf countries. His interest and research is mainly focused on minimally invasive approaches for endocrinal diseases and bariatric surgeries.
E-mail: waleedgado79@gmail.com